Why the study?
Does a cardio-endoscopic technique safely and effectively treat left ventricular tumours, thrombus, or hypertrophic myocardium?
Does a cardio-endoscopic technique safely and effectively treat left ventricular tumours, thrombus, or hypertrophic myocardium?
Cardio-endoscopic surgery appears to be a safe and effective adjunct for resecting left ventricular lesions, achieving 100% complete resection with 0% mortality in reported cases, though robust randomized trials are needed.
Answers are grounded in this paper and cite their sources.
Suggests cardio-endoscopic resection is a highly feasible adjunct for left ventricular.
Better visualisation, accurate resection and avoidance of ventriculotomy associated with use of endoscopic devices during intracardiac surgery has led to increasing interest in their use. The possibility of combining a cardio-endoscopic technique with either minimally invasive or totally endoscopic cardiac surgery provides an incentive for its further development. Several devices have been used, however their uptake has been limited due to uncertainty around their impact on patient outcomes. A systematic review of the literature identified 34 studies, incorporating 54 subjects undergoing treatment of left ventricular tumours, thrombus or hypertrophic myocardium using a cardio-endoscopic technique. There were no mortalities (0%; 0/47). In 12 studies, the follow-up period was longer than 30 days. There were no post-operative complications apart from one case of atrial fibrillation (2.2%; 1/46). Complete resection of left ventricular lesion was achieved in all cases (100%; 50/50). These successful results demonstrate that the cardio-endoscopic technique is a useful adjunct in resection of left ventricular tumours, thrombus and hypertrophic myocardium. This approach facilitates accurate resection of pathological tissue from left ventricle whilst avoiding exposure related valvular damage and adverse effects associated with ventriculotomy. Future research should focus on designing adequately powered comparative randomised trials focusing on major cardiac and cerebrovascular morbidity outcomes in both the short and long-term. In this way, we may have a more comprehensive picture of both the safety and efficacy of this technique and determine whether such devices could be safely adopted for routine use in minimal access or robotic intra-cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Soylu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: